Dr. R. Kent Galey is a Pittsburgh, Pennsylvania based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 9380 Mcknight Rd, Suite #203, Pittsburgh. Patients can reach him at 412-367-3222.
Dr. R. Kent Galey deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. R. Kent Galey speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. R. Kent Galey
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
9380 Mcknight Rd, Suite #203, Pittsburgh, Pennsylvania, 15237-5954
Phone:
412-367-3222
Fax:
412-367-3373
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
0345309340
Enrollment ID:
I20120117000398
NPI Number:
1962516260
NPI Enumeration Date:
17 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
9380 Mcknight Rd, Suite #203 Pittsburgh, Pennsylvania
Zip:
15237-5954
Phone Number:
412-367-3222
Fax Number:
412-367-3373
Patients can reach Dr. R. Kent Galey at 9380 Mcknight Rd, Suite #203, Pittsburgh, Pennsylvania or can call to book an appointment on 412-367-3222. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.